ABSTRACT
BACKGROUND: Adenosine is analgesic in humans, and the selective adenosine A1 receptor agonist GR79236X has significant anti-nociceptive activity in an animal pain model of inflammatory pain. METHODS: Seventy-nine patients with moderate pain after third molar extraction under general anaesthesia were randomized to receive a 15 min double-blind infusion containing either GR79236X 4 microg kg-1, GR79236X 10 microg kg-1, diclofenac 50 mg, or saline placebo. Rescue analgesia was promptly available to all patients. RESULTS: Meaningful pain relief (mild or no pain) was attained by 9 (47%) patients in the placebo group, 12 (63%) patients in the GR79236 4 microg kg-1 group, 10 (48%) patients in the 10 microg kg-1 group, and 16 (80%) patients in the diclofenac 50 mg group. Neither dose of GR79236 produced a significant improvement over placebo, but diclofenac was superior to both placebo (P=0.036) and GR79236 10 microg kg-1 (P=0.034). Median times to rescue or additional analgesia were 62, 100, 60, and 363 min for patients receiving placebo, GR79236 4 microg kg-1, 10 microg kg-1, and diclofenac 50 mg, respectively (diclofenac significantly longer than placebo, P=0.002 log-rank test). Pain control was poor in the placebo group and in both GR79236 groups, with between 79 and 86% of patients having good pain control (i.e. mild or no pain) for <20% of the time compared with only 30% of patients who received diclofenac. CONCLUSION: We found no evidence of efficacy of GR79236 compared with placebo, but the active control diclofenac was effective. It is possible that a higher dose of GR79236 might have been effective or that i.v. administration of this drug does not achieve appropriate concentrations in the brain or peripheral nerves.
Subject(s)
Adenosine/analogs & derivatives , Analgesics, Non-Narcotic/therapeutic use , Molar, Third/surgery , Pain, Postoperative/drug therapy , Tooth Extraction/adverse effects , Adenosine/administration & dosage , Adenosine/therapeutic use , Adolescent , Adult , Analgesics, Non-Narcotic/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Diclofenac/therapeutic use , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Middle Aged , Pain Measurement/methods , Pain, Postoperative/etiology , Purinergic P1 Receptor AgonistsABSTRACT
Sixty ASA 1 and 2 children aged between 2 and 16 years who required tracheal intubation as part of anaesthesia for elective surgery were studied. We evaluated intubating conditions, haemodynamic responses and duration of apnoea following propofol 4 mg.kg-1 combined with either remifentanil 1.25 microg.kg-1 (group R), or suxamethonium 1 mg.kg-1 (group S). Tracheal intubation was graded as excellent, good or poor according to ease of laryngoscopy, vocal cord position, coughing, and jaw relaxation and limb movement. Thirty of group S and 28 of group R children were successfully intubated on the first attempt. Overall, intubation conditions were excellent or good in 26/30 (87%) patients in group S and 20/30 (67%) in group R (p<0.05). Mean apnoea time was 190 s in group S, and 362 s in group R (p<0.001). Heart rate increased in response to suxamethonium (p<0.01) and both systolic and diastolic blood pressure decreased in the remifentanil group (p<0.01).
Subject(s)
Intubation, Intratracheal/methods , Piperidines/pharmacology , Propofol/pharmacology , Succinylcholine/pharmacology , Adolescent , Analgesics, Opioid/pharmacology , Anesthetics, Intravenous/pharmacology , Blood Pressure/drug effects , Child , Child, Preschool , Double-Blind Method , Female , Heart Rate/drug effects , Humans , Laryngoscopy , Male , Neuromuscular Depolarizing Agents/pharmacology , RemifentanilABSTRACT
A 65-year-old man developed massive hemoperitoneum secondary to spontaneous splenic rupture. Histopathological analysis of the spleen demonstrated necrotizing granulomas. Results of serological tests indicated infection with a species of Bartonella, and immunohistochemical staining established Bartonella henselae as the cause of splenitis. To our knowledge, this represents the first reported case of spontaneous splenic rupture caused by infection with a species of Bartonella.
Subject(s)
Bartonella Infections/complications , Bartonella henselae , Splenic Rupture/microbiology , Aged , Angiomatosis, Bacillary , Antibodies, Bacterial/blood , Bartonella Infections/diagnosis , Bartonella henselae/immunology , Bartonella henselae/isolation & purification , Fluorescent Antibody Technique, Indirect , Granuloma/microbiology , Hemoperitoneum/microbiology , Humans , Immunohistochemistry , Lymph Nodes/microbiology , Male , Rupture, Spontaneous/microbiology , Rupture, Spontaneous/pathology , Spleen/microbiology , Splenic Rupture/pathologyABSTRACT
Postoperative analgesia in patients who receive regular oral opioids pre-operatively is frequently suboptimal. To improve management we introduced a regimen using subcutaneous diamorphine infusions with incremental doses. Infusion doses were calculated as half the daily pre-operative dose of oral morphine with the increments as one-sixth of the infusion dose. Results were recorded on the first two postoperative days before (n = 13) and after (n = 23) commencing the new regimen. The percentage of patients reporting severe pain at rest and on movement were significantly reduced by the new regimen (54% and 69% vs. 13% and 40%, respectively) since the opioid dose as a percentage of the pre-operative dose was significantly higher (160% vs. 352%). There were no instances of excessive sedation or slow respiratory rate in any patient. The use of the regimen has resulted in greater doses of opioids being administered with fewer patients in severe pain without significant complications.
Subject(s)
Analgesics, Opioid/therapeutic use , Heroin/therapeutic use , Pain, Postoperative/drug therapy , Adult , Aged , Aged, 80 and over , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Chronic Disease , Drug Administration Schedule , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Pain Measurement , Treatment OutcomeABSTRACT
Pseudallescheria boydii and its asexual form, Scedosporium apiospermum, are ubiquitous, saprophytic fungi that commonly cause cutaneous infection. However, in certain circumstances, P. boydii can also cause invasive disease, which can involve the central nervous system (CNS). When the CNS becomes involved, treatment is difficult, therapeutic options are limited, and the prognosis is poor. We report a case of Pseudallescheria brain abscess successfully treated with surgical drainage and systemic voriconazole, the first such case to be described in the literature. We also review previously reported cases of CNS pseudallescheriasis and evaluate therapeutic options.
Subject(s)
Antifungal Agents/therapeutic use , Brain Abscess/drug therapy , Mycoses/drug therapy , Pseudallescheria/drug effects , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Brain Abscess/microbiology , Brain Abscess/surgery , Central Nervous System/drug effects , Central Nervous System/microbiology , Central Nervous System/surgery , Drainage/methods , Humans , Male , Middle Aged , Mycoses/microbiology , Mycoses/surgery , VoriconazoleABSTRACT
Isolated pulmonary cryptococcosis (IPC) is an infrequently diagnosed infection, the management of which is not well defined. In past years, IPC traditionally has not been treated in the immunocompetent host, given its perceived benign and self-limited course and the toxicity associated with amphotericin B. However, some patients manifest prominent and disabling symptoms, and infection occasionally may disseminate. Fluconazole is active against Cryptococcus neoformans, is easily administered, and has an excellent safety profile. We present four healthy hosts with IPC who were treated with oral fluconazole for 6 to 8 weeks. A review of the literature was conducted to identify other cases of IPC in healthy hosts who were also treated with fluconazole. Our results and the limited experience reported in the literature suggest that fluconazole may be an appropriate choice for the treatment of IPC in the immunocompetent host. Indications for treatment are not defined, but symptomatic patients, those with multiple nodules or extensive infiltrates on chest radiographs, and/or those testing positive for serum cryptococcal antigen might be potential candidates for therapy.
Subject(s)
Antifungal Agents/administration & dosage , Cryptococcosis/drug therapy , Fluconazole/administration & dosage , Immunocompromised Host , Lung Diseases, Fungal/drug therapy , Administration, Oral , Aged , Antibodies, Fungal/analysis , Antigens, Fungal/immunology , Biopsy, Needle , Cryptococcosis/diagnosis , Cryptococcosis/immunology , Cryptococcosis/microbiology , Cryptococcus neoformans/immunology , Cryptococcus neoformans/isolation & purification , Female , Humans , Immunocompromised Host/drug effects , Immunocompromised Host/immunology , Lung Diseases, Fungal/diagnosis , Lung Diseases, Fungal/immunology , Lung Diseases, Fungal/microbiology , Male , Middle Aged , Tomography, X-Ray ComputedSubject(s)
Alcoholic Intoxication/therapy , Emergency Treatment/standards , Hematoma, Subdural/therapy , Malpractice/legislation & jurisprudence , Emergency Nursing/legislation & jurisprudence , Emergency Treatment/methods , Emergency Treatment/nursing , Fatal Outcome , Humans , Male , Middle Aged , Nursing Staff, Hospital/legislation & jurisprudenceABSTRACT
Chronic pain is common among hospital inpatients. Patients with chronic pain have low expectations of pain relief. The patient's need for information is frequently not met.
Subject(s)
Attitude to Health , Pain/prevention & control , Pain/psychology , Patient Admission/standards , Acute Disease , Chronic Disease , Humans , Pain/etiology , Pain/nursing , Pain Measurement , Patient Education as Topic/methods , Risk Factors , Surveys and QuestionnairesABSTRACT
Mycotic processes occasionally complicate atherosclerotic aortic disease and usually require aggressive surgical therapy to control sepsis and prevent arterial rupture. Rarely, fungal organisms are responsible for primary infection of the abdominal aorta. We report the first case of Cryptococcal aortitis presenting as a ruptured abdominal aortic aneurysm. The surgical, pathologic, and microbiologic aspects of fungal aortitis are discussed.
Subject(s)
Aneurysm, Infected/complications , Aneurysm, Ruptured/etiology , Aortic Aneurysm, Abdominal/etiology , Aortitis/microbiology , Cryptococcosis/complications , Antifungal Agents/therapeutic use , Aortitis/complications , Cryptococcosis/drug therapy , Humans , Male , Middle AgedABSTRACT
There are few data in the literature that describe the use of remifentanil when administered as a component of an inhalation or total i.v. anaesthetic (TIVA) technique. We studied 251 male and female patients, aged 18-75 years, ASA I-II, undergoing inguinal hernia repair, arthroscopic knee surgery or varicose vein surgery of at least 30 min duration without premedication. Patients were randomized to receive a remifentanil loading dose of 1.0 microgram kg-1 followed by a continuous infusion of 0.5 microgram kg-1 min-1 in combination with isoflurane (end-tidal concentration 0.6%), (Group I, n = 115) or propofol (initial infusion rate 9 mg kg-1 h-1 reduced to 6 mg kg-1 h-1 after 10 min), (Group P, n = 118). The remifentanil infusion rate was reduced by 50%, 5 min after tracheal intubation. Intraoperative stresses were treated with a remifentanil bolus (1 microgram kg-1) followed by an increase in the remifentanil infusion rate. At the insertion of the last suture, the remifentanil infusion and concomitant anaesthetic were switched off simultaneously. Times to spontaneous respiration, adequate respiration and tracheal extubation were significantly shorter in group I compared with group P (6.4 min vs 7.6 min, P < 0.01; 7.6 min vs 9.3, P < 0.003; 7.8 min vs 9.5 min, P < 0.015). Overall mean systolic blood pressures during surgery were greater in group P compared with group I (P < 0.05) but the absolute differences were clinically insignificant (4-5 mm Hg).
Subject(s)
Analgesics, Opioid , Anesthetics, Inhalation , Anesthetics, Intravenous , Piperidines , Adolescent , Adult , Aged , Female , Humans , Isoflurane , Length of Stay , Male , Middle Aged , Pain, Postoperative/prevention & control , Postoperative Complications , Propofol , Prospective Studies , RemifentanilABSTRACT
UNLABELLED: The purpose of this article is to review the potential role of nuclear medicine scanning, especially with 67Ga, in the presumptive diagnosis and clinical management of patients with renal parenchymal malacoplakia (RPMP), a rare disease associated with coliform bacterial infection of the kidney and characterized by chronic unresolving inflammatory infiltrates containing von Hansemann macrophages in the renal parenchyma. METHODS: Published cases of RPMP were collected from the archival literature by searching the MEDLINE database and by reviewing bibliographic references contained in articles on malacoplakia. Data on the clinical features and radiographic evaluation of patients with RPMP were extracted from the clinical case reports. RESULTS: Forty-three cases of RPMP published over the past 20 yr were identified. Ten of the 43 patients (23%) had 67Ga scanning as a component of their diagnostic evaluation. In all 10 patients, renal uptake of 67Ga was classified as intense. Two of those 10 patients had serial 67Ga scanning performed to assess response to antibiotic treatment; both patients exhibited decreased uptake or complete resolution of abnormal renal uptake over time, a finding also exhibited by our patient. CONCLUSION: Intense renal uptake of 67Ga, typically in the clinical setting of fever, progressive renal failure and nephromegaly, strongly supports a diagnosis of RPMP. In those patients receiving prolonged antimicrobial therapy for RPMP, resolution of abnormal 67Ga uptake over time may provide an objective endpoint for treatment.
Subject(s)
Citrates , Gallium Radioisotopes , Gallium , Kidney Diseases/diagnostic imaging , Malacoplakia/diagnostic imaging , Radiopharmaceuticals , Anti-Infective Agents/therapeutic use , Ascorbic Acid/therapeutic use , Ciprofloxacin/therapeutic use , Female , Humans , Middle Aged , Radionuclide Imaging , Rifampin/therapeutic useABSTRACT
In the present report we describe 4 previously healthy women who developed cryptococcal pneumonia during pregnancy, and 1 pregnant woman with cryptococcal meningitis. These cases illustrate a previously uncharacterized spectrum of cryptococcal disease. We also discuss 24 patients previously reported who had cryptococcal meningitis during pregnancy. Finally, we review the available data for each therapeutic option and present an algorithm for management based on appraisals of disease severity and risk to the unborn fetus. This report emphasizes the need for heightened awareness of cryptococcosis in the differential diagnosis of pneumonia, chest pain, and hypoxemia in the pregnant patient, but at present, there are insufficient epidemiologic data to determine whether incidences of pulmonary or disseminated cryptococcosis actually increase during pregnancy. The risk of congenital cryptococcosis to the unborn fetus is low, and the most likely mechanism whereby neonates acquire invasive fungal pulmonary infection is through aspiration. While it is unclear whether there is any real increased risk of spontaneous abortion or premature labor, the data indicate that overall fetal outcome depends on effective treatment of maternal infection. For patients with dense air-space consolidation, progressive pulmonary disease, or dissemination, antifungal therapy is necessary. Optimal treatment is determined by the acuity and severity of the clinical presentation. Amphotericin B (approximately 1 g) with or without flucytosine represents the choice for initial treatment of the more acutely ill patient with disseminated or progressive pulmonary cryptococcosis who requires hospitalization (whether during or after pregnancy). Oral fluconazole appears to be safe and effective alternative therapy after delivery for the less severely ill patient who can be managed on an outpatient basis. While the use of fluconazole during pregnancy generally appears safe in terms of fetal outcome (49, 58), the class C status and single report of fetal malformation (62) preclude confident recommendation for its use during pregnancy. The risks and benefits of this effective and generally less toxic drug should be discussed with the parents and weighed against the use of amphotericin B. For pregnant women with limited pulmonary cryptococcosis (segmental or nodular infiltrates) and no evidence of dissemination, we recommend close follow-up without antifungal therapy similar to the recommendation for normal hosts with minimal disease. However, it is important to note that there is no extensive experience upon which to base this recommendation for pregnant individuals (45, 55, 103, 108). It is prudent to use frequent physical examinations (for example, every 1-2 months), combined with chest roentgenograms and serum cryptococcal antigens to monitor progression and/or development of disease in both the mother and child for approximately 6 months postpartum. In conclusion, cryptococcosis during pregnancy presents a special challenge to the clinician. A balanced therapeutic approach holds great promise for successful maternal and fetal outcomes.
Subject(s)
Cryptococcosis/diagnosis , Cryptococcosis/microbiology , Cryptococcus neoformans/isolation & purification , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/microbiology , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/microbiology , Adult , Biopsy , Female , Humans , Lung/microbiology , Lung/pathology , Pregnancy , Tomography, X-Ray ComputedABSTRACT
The predictive performance of a 'Diprifusor' target controlled infusion system for propofol was examined in 46 patients undergoing major surgery, divided into three age groups (18-40, 41-55 and 56-80 years). Measured arterial propofol concentrations were compared with values calculated (predicted) by the target controlled infusion system. Performance indices (median performance error and median absolute performance error) were similar in the three age groups, with study medians of 16.2% and 24.1%, respectively. Mean values for 'divergence' and 'wobble' were -7.6%.h-1 and 21.9%, respectively. Measured concentrations tended to be higher than calculated concentrations, particularly following induction or an increase in target concentration. The mean (SD) propofol target concentration of 3.5 (0.7) micrograms.ml-1 during maintenance was lower in older patients, compared with higher target concentrations of 4.2 (0.6) and 4.3 (0.7) micrograms.ml-1 in the two younger age groups, respectively. The control of depth of anaesthesia was good in all patients and the predictive performance of the 'Diprifusor' target controlled infusion system was considered acceptable for clinical purposes.
Subject(s)
Anesthesia, Intravenous/instrumentation , Infusion Pumps , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Anesthetics, Intravenous/administration & dosage , Anesthetics, Intravenous/blood , Decision Making, Computer-Assisted , Female , Humans , Male , Middle Aged , Propofol/administration & dosage , Propofol/bloodABSTRACT
We have investigated the effect of four doses of remifentanil on the incidence of respiratory depression and somatic response at incision. Remifentanil was administered as a loading dose of 0.125, 0.25, 0.375 or 0.5 microgram kg-1 and at a maintenance infusion rate of 0.025, 0.05, 0.075 or 0.1 microgram kg-1 min-1, respectively, with an infusion of propofol 6 mg kg-1 h-1. Responses occurred in 88% of patients with remifentanil 0.025 microgram kg-1 min-1 compared with 30-40% in the other groups. Respiratory depression after incision increased from 6% with remifentanil 0.025 microgram kg-1 min-1 to 73% with 0.1 microgram kg-1 min-1. Increases in propofol infusion rate to 7.2-8.4 mg kg-1 h-1 produced adequate maintenance of anaesthesia. Reductions in remifentanil doses to 0.025-0.05 microgram kg-1 min-1 resulted in adequate respiration at the end of surgery in 88% of patients. Maintenance infusions of the two drugs for spontaneous ventilation are likely to be in these ranges. However, the ideal loading doses and infusion rates for induction remain to be established.
Subject(s)
Analgesics, Opioid/administration & dosage , Anesthetics, Intravenous , Piperidines/administration & dosage , Propofol , Respiration/drug effects , Adolescent , Adult , Aged , Analgesics, Opioid/adverse effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Interactions , Female , Humans , Male , Middle Aged , Piperidines/adverse effects , Remifentanil , Respiratory Insufficiency/chemically inducedABSTRACT
BACKGROUND: We have previously shown that in a randomized comparison of laparoscopic (LC) versus small incision (SC) cholecystectomy, postoperative hospital stay is comparable. This randomized prospective study compares the postoperative pain, analgesic and antiemetic consumption, perceived health, and metabolic and respiratory responses after these two procedures. METHODS: Two hundred patients were recruited; postoperative stay, pain scores, analgesic and antiemetic consumption were recorded. Nottingham Health Profile questionnaires were completed by a subgroup of 100 patients, and the metabolic and respiratory responses were also compared in a further subgroup of 20 patients. RESULTS: Pain scores in both groups were low. LC, however, was associated with lower postoperative pain scores and analgesic requirements compared with SC, but the antiemetic requirements were greater after LC. The duration of hospital stay and the perceived health after operation were the same in both groups, and both procedures were associated with a similar reduction of respiratory function. Twenty-four hours after operation the inflammatory (C-reactive protein, CRP) response to LC (22 +/- 20 mg/L) was significantly lower than after SC (68 +/- 30 mg/L), but the neuroendocrine (cortisol) response was similar (LC, 475 +/- 335 nmol/L, compared with SC, 710 +/- 410 nmol/L). Independent of the technique used, the duration of postoperative hospital stay correlated significantly with the magnitude of both the 24-hour postoperative cortisol and CRP responses (cortisol: rs = 0.678, p < 0.001; CRP: rs = 0.566, p = 0.011). CONCLUSIONS: LC appears to be associated with less tissue destruction and pain than SC, but this did not confer any advantage in the degree of postoperative respiratory impairment, length of hospital stay, or postoperative perceived health. The neuroendocrine component of the metabolic response evoked by each procedure was similar and had a significant correlation to patient's postoperative hospital stay. This finding may explain the similar postoperative recovery after LC and SC.
Subject(s)
Attitude to Health , Blood Glucose/metabolism , Cholecystectomy, Laparoscopic , Cholecystectomy , Health Status Indicators , Pain, Postoperative , Respiratory Function Tests , Adult , Aged , Analgesics/therapeutic use , Antiemetics/therapeutic use , C-Reactive Protein/analysis , Double-Blind Method , Emotions , Female , Humans , Hydrocortisone/blood , Inflammation , Length of Stay , Male , Middle Aged , Pain Measurement , Pain, Postoperative/drug therapy , Prospective StudiesSubject(s)
Anemia/chemically induced , Anti-HIV Agents/adverse effects , HIV Infections/drug therapy , Lamivudine/adverse effects , Zidovudine/adverse effects , Adult , Anti-HIV Agents/therapeutic use , Drug Interactions , Drug Therapy, Combination , Female , Humans , Lamivudine/therapeutic use , Male , Middle Aged , Zidovudine/therapeutic useABSTRACT
Postoperative nausea and vomiting (PONV) frequently follows prominent ear correction under general anaesthesia in children. In a prospective, single-blind study, we compared the incidence of PONV after propofol infusion anaesthesia with that following thiopentone induction and isoflurane maintenance in 30 children aged from four to 14 years randomly allocated to one of two groups. All the children were mechanically ventilated. Anaesthesia was supplemented in both groups with nitrous oxide and infiltration of the ears using a mixture of bupivacaine, adrenaline, and hyaluronidase. One child receiving propofol (group P) complained of nausea, compared with eight receiving thiopentone/ isoflurane, (group T) (P = 0.005), while three children in group P and ten in group T vomited before hospital discharge, (P = 0.01). Eight children in group P were considered to be fit for discharge on the day of surgery as against four in group T, (not significant). Only four out of twelve children receiving opioid analgesia vomited.
Subject(s)
Anesthetics, Combined , Anesthetics, Inhalation , Anesthetics, Intravenous , Ear, External/surgery , Isoflurane , Propofol , Thiopental , Adolescent , Anesthesia Recovery Period , Anesthesia, General , Anesthetics, Intravenous/adverse effects , Child , Child, Preschool , Ear, External/abnormalities , Humans , Isoflurane/adverse effects , Nausea/chemically induced , Pain, Postoperative/drug therapy , Propofol/adverse effects , Prospective Studies , Single-Blind Method , Thiopental/adverse effects , Vomiting/chemically inducedABSTRACT
OBJECTIVES: To assess the changing epidemiology of candidemia in the 1990s, to evaluate the clinical implications for the presence of non-Candida albicans in blood, and to evaluate the presence of antifungal resistance in relation to prior antifungal administration. DESIGN: Multicenter prospective observational study of patients with positive blood cultures for Candida species or Torulopsis glabrata. SETTING: Four tertiary care medical centers. RESULTS: Four hundred twenty-seven consecutive patients were enrolled. The frequency of candidemia due to non-C. albicans species significantly increased in each hospital throughout the 3.5-year study period (P = 0.01). Thirteen percent of candidemias occurred in patients who were already receiving systemic antifungal agents. Candidemias developing while receiving antifungal therapy were more likely caused by non-C. albicans species than by C. albicans species (P = 0.0005). C. parapsilosis and C. krusei were more commonly seen with prior fluconazole therapy, whereas T. glabrata was more commonly seen with prior amphotericin B therapy. Candida species isolated during episodes of breakthrough candidemia exhibited a significantly higher MIC to the antifungal agent being administered (P < 0.001). CONCLUSION: In this large scale study, the non-C. albicans species, especially T. glabrata, emerged as important and frequent pathogens causing fungemia. This finding has major clinical implications given the higher complication and mortality rate associated with the non-C. albicans species. The change in the pattern of candidemia might be partly attributed to the increase in number of immunocompromised hosts and the widespread use of prophylactic or empiric antifungal therapy. This is an ominous sign given the in vitro resistance of the non-C. albicans species to currently available antifungal agents.
Subject(s)
Antifungal Agents/therapeutic use , Candidiasis/microbiology , Fungemia/microbiology , Amphotericin B/therapeutic use , Candida albicans , Candidiasis/drug therapy , Drug Resistance, Microbial , Fluconazole/therapeutic use , Fungemia/drug therapy , Humans , Incidence , Microbial Sensitivity Tests , Multivariate Analysis , Prospective Studies , Risk , Risk FactorsABSTRACT
BACKGROUND: Hypoventilation may occur following induction of anaesthesia with propofol and is potentiated by concurrent use of opioid drugs. This effect is undesirable in patients who will continue to maintain spontaneous respiration during anaesthesia and surgery. The analeptic drug doxapram is known to have selective respiratory stimulatory effects but its action during induction of anaesthesia has been inconsistent. METHOD: In a double-blind, placebo-controlled study, the influence of alfentanil pre-treatment on the ventilatory effects of doxapram given during induction of anaesthesia with propofol was studied in 40 patients. Four groups of ten patients (two groups pre-treated with 7 micrograms.kg-1 of alfentanil and two groups with saline) were randomly allocated to receive either 0.5 mg.kg-1 doxapram or saline following infusion of propofol to loss of verbal contact. RESULTS: In the groups that received doxapram, minute volumes were significantly increased and end-tidal carbon dioxide concentrations were significantly reduced compared to control groups, although the duration and extent of these effects were less in the group that received alfentanil. Doxapram also reversed an alfentanil-induced reduction in respiratory rate. No adverse cardiovascular or neurological stimulatory effects of doxapram were evident at any time. CONCLUSION: We conclude that doxapram 0.5 mg.kg-1 is effective in augmenting ventilation that has been obtunded following induction of anaesthesia with propofol in patients pre-treated with alfentanil.